Attached files

file filename
10-K - Breitling Energy Corpv183201_10k.htm
EX-31.2 - Breitling Energy Corpv183201_ex31-2.htm
EX-32.1 - Breitling Energy Corpv183201_ex32-1.htm
EX-31.1 - Breitling Energy Corpv183201_ex31-1.htm

EXHIBIT 32.2

CERTIFICATION OF PRINCIPAL FINANCIAL OFFICER
PURSUANT TO 18 U.S.C. SECTION 1350,
AS ADOPTED PURSUANT TO SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

I, J. Leonard Ivins,  certify, pursuant to 18 U.S.C. Section 1350, as adopted  pursuant  to  Section  906 of the Sarbanes-Oxley Act of 2002, that the Annual Report of Oncolin Therapeutics, Inc. on Form 10-K for the annual period ended March 31, 2009, fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934 and that information contained in such  Form 10-K fairly presents in all material respects the financial condition and results of operations of Oncolin Therapeutics, Inc.

Date:  May 4, 2010

By:
  /s/ J. Leonard Ivins
 
 
J. Leonard Ivins
 
Principal Financial and Accounting Officer